HCHong Wei Chu

Hong Wei Chu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hong Wei Chu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Richard J. Martin

    Department of Medicine, National Jewish Medical and Research Center, and the University of Colorado Health Sciences Center, Denver, Colorado

    6 shared publications
  • John G. Rino

    Department of Medicine, National Jewish Medical and Research Center, and the University of Colorado Health Sciences Center, Denver, Colorado

    5 shared publications
  • Qun Wu

    National Jewish Medical and Research Center, 1400 Jackson Street, Room A639, Denver, CO 80206, USA

    3 shared publications
  • Rachel Breed

    Department of Medicine, National Jewish Medical and Research Center and the University of Colorado Health Sciences Center , Denver, CO 80206

    3 shared publications
  • Ronald J. Harbeck

    Department of Medicine, National Jewish Medical and Research Center, and the University of Colorado Health Sciences Center, Denver, Colorado

    3 shared publications
  • Sally E. Wenzel

    University of Colorado Health Sciences Center, Denver, Colorado

    2 shared publications

Latest Publications

  • Toll-like Receptor 2 Down-regulation in Established Mouse Allergic Lungs Contributes to Decreased Mycoplasma Clearance

    by Qun Wu, Richard J. Martin, Spencer LaFasto, Benjamin J. Efaw, John G. Rino, Ronald J. Harbeck, Hong Wei Chu

    Rationale: Respiratory Mycoplasma pneumoniae (Mp) infection is involved in asthma pathobiology, but whether the established allergic airway inflammation compromises lung innate immunity and subsequently predisposes patients with asthma to Mp infection remains unknown. Objectives: To test whether the established allergic airway inflammation compromises host innate immunity (e.g., Toll-like receptor 2 [TLR2]) to hinder the elimination of Mp from the lungs. Methods: We used mouse models of ovalbumin (OVA)-induced allergic airway inflammation with an ensuing Mp infection, and cultures of mouse primary lung dendritic cells (DCs) and bone marrow–derived DCs. Measurements and Main Results: Lung Mp clearance in allergic mice and TLR2 and IL-6 levels in lung cells, including DCs as well as cultured primary lung DCs and bone marrow–derived DCs, were assessed. The established OVA-induced allergic airway inflammation, or the prominent Th2 cytokines IL-4 and IL-13, inhibited TLR2 expression and IL-6 production in lung cells, including lung DCs, and eventually led to impaired host defense against Mp. Studies in IL-6 knockout mice indicated that IL-6 directly promoted Mp clearance from the lungs. IL-4– and IL-13–induced suppression of TLR2 was mediated by inhibiting nuclear factor-κB activation through signal transducer and activator of transcription 6 (STAT6) signaling pathway. Conclusions: The established OVA-induced allergic airway inflammation impairs TLR2 expression and host defense cytokine (e.g., IL-6) production, and subsequently delays lung bacterial clearance. This could offer novel therapeutic strategies to reinstate TLR2 activation by using TLR2 ligands and/or blocking IL-4 and IL-13 to ameliorate persisting respiratory bacterial infections in allergic lungs.


  • Function and Regulation of SPLUNC1 Protein in Mycoplasma Infection and Allergic Inflammation

    by Hong Wei Chu, Jyoti Thaikoottathil, John G. Rino, Gongyi Zhang, Qun Wu, Taylor Moss, Yosef Refaeli, Russell Bowler, Sally E Wenzel, Zhongzhou Chen, et al.

    Respiratory infections, including Mycoplasma pneumoniae (Mp), contribute to asthma pathobiology. To date, the mechanisms underlying the increased susceptibility of asthmatics to airway Mp infection remain unclear. Short palate, lung, and nasal epithelium clone 1 (SPLUNC1) protein is a recently described large airway epithelial cell-derived molecule that was predicted to exert host defense activities. However, SPLUNC1 function and regulation in an infectious or allergic milieu are still unknown. We determined host defense and anti-inflammatory functions of SPLUNC1 protein in Mp infection and the regulation of SPLUNC1 by Mp and allergic inflammation (e.g., IL-13). SPLUNC1 function was examined in Mp or human airway epithelial cell cultures by using SPLUNC1 recombinant protein, overexpression and RNA interference. Human and mouse bronchial epithelial SPLUNC1 was examined using immunostaining, Western blotting, ELISA, laser capture microdissection, and real-time PCR. Mouse models of Mp infection and allergic inflammation and air-liquid interface cultures of normal human primary bronchial epithelial cells were used to study SPLUNC1 regulation by Mp and IL-13. We found that: 1) SPLUNC1 protein decreased Mp levels and inhibited epithelial IL-8 production induced by Mp-derived lipoproteins; 2) normal human and mouse large airway epithelial cells expressed high levels of SPLUNC1; and 3) although Mp infection increased SPLUNC1, IL-13 significantly decreased SPLUNC1 expression and Mp clearance. Our results suggest that SPLUNC1 serves as a novel host defense protein against Mp and that an allergic setting markedly reduces SPLUNC1 expression, which may in part contribute to the persistent nature of bacterial infections in allergic airways.


  • Repeated respiratory Mycoplasma pneumoniae infections in mice: effect of host genetic background

    by Hong Wei Chu, Rachel Breed, John G. Rino, Ronald J. Harbeck, Michael R. Sills, Richard J. Martin


  • Open Access

    Mycoplasma pneumoniaeinfection increases airway collagen deposition in a murine model of allergic airway inflammation

    by Hong Wei Chu, John G. Rino, Rachel B. Wexler, Krista Campbell, Ronald J. Harbeck, Richard J. Martin

    Mycoplasma pneumoniae (Mp) has been linked to chronic asthma. Airway remodeling (e.g., airway collagen deposition or fibrosis) is one of the pathological features of chronic asthma. However, the effects of respiratory Mp infection on airway fibrosis in asthma remain unclear. In the present study, we hypothesized that respiratory Mp infection may increase the airway collagen deposition in a murine model of allergic airway inflammation in part through upregulation of transforming growth factor (TGF)-β1. Double (2 wk apart) inoculations of Mp or saline (control) were given to mice with or without previous allergen (ovalbumin) challenges. On days 14 and 42 after the last Mp or saline, lung tissue and bronchoalveolar lavage (BAL) fluid were collected for analyses of collagen and TGF-β1 at protein and mRNA levels. In allergen-naïve mice, Mp did not alter airway wall collagen. In allergen-challenged mice, Mp infections did not change airway wall collagen deposition on day 14 but increased the airway collagen on day 42; this increase was accompanied by increased TGF-β1 protein in the airway wall and reduced TGF-β1 protein release from the lung tissue into BAL fluid. Our results suggest that Mp infections could modulate airway collagen deposition in a murine model of allergic airway inflammation with TGF-β1 involved in the collagen deposition process.


  • Transforming Growth Factor-β2 Induces Bronchial Epithelial Mucin Expression in Asthma

    by Hong Wei Chu, Silvana Balzar, Gregory J. Seedorf, Jay Y. Westcott, John B. Trudeau, Phil Silkoff, Sally E. Wenzel


  • Expression and activation of 15‐lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition

    by H. W. Chu, S. Balzar, J. Y. Westcott, J. B. Trudeau, Y. Sun, D. J. Conrad, S. E. Wenzel

    Summary: Background Although 15(S)‐hydroxyeicosatetraenoic acid (15(S)‐HETE), a product of 15‐lipoxygenase (15‐LO), may be involved in mild to moderate asthma, little is known about its potential roles in severe asthma.Objectives This study was performed to evaluate 15(S)‐HETE levels in bronchoalveolar lavage fluid (BALF) from severe asthmatics with and without airway eosinophils and from the control groups. In addition, 15‐LO protein expression was examined in endobronchial biopsy, while its expression and activation were evaluated in BAL cells.Results While 15(S)‐HETE levels in BALF were significantly higher in all severe asthmatics than normal subjects, severe asthmatics with airway eosinophils had the highest levels compared with mild, moderate asthmatics and normal subjects. 15(S)‐HETE levels were associated with tissue eosinophil numbers, sub‐basement membrane thickness and BALF tissue inhibitor of metalloproteinase‐1 levels, and were accompanied by increased 15‐LO expression in bronchial epithelium. In addition, activation of 15‐LO was suggested by the increased proportion of 15‐LO in the cytoplasmic membrane of alveolar macrophages from severe asthmatics.Conclusion The data suggest that severe asthmatics with persistent airway eosinophils manifest high levels of 15(S)‐HETE in BALF, which may be associated with airway fibrosis. It is likely that 15‐LO expression and activation by airway cells explain the increased 15(S)‐HETE levels.


  • Collagen Deposition in Large Airways May Not Differentiate Severe Asthma from Milder Forms of the Disease

    by Hong Wei Chu, Janet L. Halliday, Richard J. Martin, Donald Y. M. Leung, Stanley J. Szefler, Sally E. Wenzel

    Chronic airway inflammation and remodeling, including fibrosis, have been proposed as important contributors to asthma pathophysiology. Previous studies of airway fibrosis have been performed mainly in mild and moderate asthmatics at the subepithelial “basement membrane” (SBM) level. The current study was designed to evaluate the large airway SBM thickness and submucosal collagen deposition, as measured by three different collagen staining methods, in endobronchial biopsies from 17 severe, nine moderate, and seven mild asthmatics, as well as eight normal control subjects. Tissue eosinophils and transforming growth factor- β (TGF- β ) immunoreactivity were also examined. There were no statistically significant differences in the SBM thickness, submucosal collagen deposition, eosinophil numbers, or TGF- β positive cells among the three groups of asthmatics and the normal control subjects. It was only when examining all asthmatics (n = 33) together, that a modestly thickened SBM (p = 0.04), as evaluated by collagen type III immunostaining, was observed as compared with normal control subjects. Despite this difference, no significant differences were found in the amount of submucosal collagen deposition and the number of eosinophils or TGF- β expressing cells when comparing total asthmatics and normal control subjects. Additionally, no significant correlations were found between collagen deposition and eosinophil count, TGF- β expression level, FEV1, or duration of asthma. These results suggest that although increased collagen deposition in the SBM at the large airway level is a characteristic of asthma, it may not explain the differences in severity of asthma.